|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 557.60 USD | +2.58% |
|
+5.79% | -0.72% |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| 06-05 | PriorNilsson Evolve Global rose 3.64 percent in May - trimmed positions in Beijer Alma and OEM | FW |
| Market Cap | 15.92B 13.92B 12.79B 11.93B 22.62B 1,516B 22.96B 154B 59.71B 745B 59.78B 58.49B 2,568B | P/E 2026 * |
32.7x | P/E 2027 * | 30x |
|---|---|---|---|---|---|
| Enterprise Value | 14.76B 12.9B 11.85B 11.05B 20.96B 1,405B 21.28B 142B 55.33B 691B 55.39B 54.2B 2,380B | EV / Sales 2026 * |
5.32x | EV / Sales 2027 * | 4.85x |
| Free-Float |
80.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | +2.58% | ||
| 1 week | +5.79% | ||
| Current month | +5.29% | ||
| 1 month | +23.69% | ||
| 3 months | +11.89% | ||
| 6 months | -2.35% | ||
| Current year | -0.72% |
| 1 week | 522.94 |  | 562.47 |
| 1 month | 442.95 | | 562.47 |
| Current year | 373 | | 628.92 |
| 1 year | 306.7 | | 628.92 |
| 3 years | 227.21 | | 628.92 |
| 5 years | 126.94 | | 628.92 |
| 10 years | 21.76 | | 628.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 2021-07-31 |
Reinilde Heyrman
CTO | Chief Tech/Sci/R&D Officer | 65 | 2017-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 55 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 72 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Fiscal year | Director | 72 | 0.0003% | ||
| 06-29 | Fiscal year | Director | 56 | 0.0002% | ||
| 06-29 | Fiscal year | Director | 66 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| -1.14% | +1.88% | +15.30% | -28.79% | 13.26B | |
| Average | +1.84% | +5.99% | +72.74% | +103.73% | 25.89B | |
| Weighted average by Cap. | +1.90% | +6.58% | +86.61% | +128.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.77B 2.43B 2.23B 2.08B 3.94B 264B 4B 26.76B 10.4B 130B 10.41B 10.19B 447B | 2.95B 2.58B 2.37B 2.21B 4.19B 281B 4.25B 28.42B 11.05B 138B 11.06B 10.82B 475B |
| Net income | 492M 430M 396M 369M 699M 46.88B 710M 4.75B 1.85B 23.04B 1.85B 1.81B 79.4B | 539M 471M 433M 404M 766M 51.34B 778M 5.2B 2.02B 25.24B 2.02B 1.98B 86.97B |
| Net Debt | -1.17B -1.02B -939M -875M -1.66B -111B -1.69B -11.27B -4.38B -54.71B -4.39B -4.29B -189B | -1.62B -1.41B -1.3B -1.21B -2.3B -154B -2.33B -15.6B -6.07B -75.72B -6.07B -5.94B -261B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$557.60 | +2.58% | 356,575 |
| 26-07-01 | US$543.57 | +2.64% | 312,635 |
| 26-06-30 | US$529.59 | -0.96% | 335,554 |
| 26-06-29 | US$534.72 | +1.45% | 390,789 |
| 26-06-26 | US$527.07 | +1.37% | 399,920 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDP Stock
Select your edition
All financial news and data tailored to specific country editions
